Actos Attorney -- Bladder Cancer Lawyer

The risk of bladder cancer is 40 percent greater in patients taking Actos for longer than two years.

The FDA has issued an Actos warning stating that the diabetes drug is linked to bladder cancer. Actos (pioglitazone) is an oral drug approved by the FDA in 1999 for the treatment of type 2 diabetes.

Data linking pioglitazone to bladder cancer was first observed in animal studies back in 1999. Cancer has been reported in both Actos animal studies and human clinical trials for years, placing the legal obligation on Takeda to update its Actos package insert. If you took Actos and now have bladder cancer call Baum Hedlund now for a free no obligation consultation at 1-800-827-0087. www.actosbladdercancer.com

Category:

News & Politics

Tags:

• Actos
• Diabetes
• Drug
• Bladder
• Cancer
• Side
• Effects
• Baum
• Hedlund
• FDA
• Warning
• Takeda
• Pharmaceutical
• Pioglitazone
• health